Matthew Lee

Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring <i>MET</i> Exon 14 Mutations and Overcomes Mutation-mediated Resistance to Type I MET Inhibitors in Nonclinical Models

Lars D. Engstrom, Ruth Aranda, Matthew Lee et al. · Clinical Cancer Research · 2017 · 147 citations · Full text

Medicine, Oncology, Pharmacology +14

Predicting the difficult laparoscopic cholecystectomy: development and validation of a pre-operative risk score using an objective operative difficulty grading system

Ahmad H. M. Nassar, James Hodson, Hwei Jene Ng et al. · Surgical Endoscopy · 2019 · 133 citations

Medicine, Perioperative Medicine, Surgery +16

Transcriptomic heterogeneity in multifocal prostate cancer

Simpa S. Salami, Daniel H. Hovelson, Jeremy Kaplan et al. · JCI Insight · 2018 · 106 citations · Full text

Medicine, Oncology, Urology +17

Preoperative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective U.K. database of 8820 patients

Robert P. Sutcliffe, Marianne Hollyman, James Hodson et al. · HPB · 2016 · 104 citations · Full text

Medicine, Perioperative Medicine, Surgery +15

Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series

Longbin Liu, Mark H. Norman, Matthew Lee et al. · Journal of Medicinal Chemistry · 2012 · 78 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +14